NPPA must balance access with innovation4 min read 20 Mar 2018, 01:26 AM IST
There is a need to induce more competition on the one hand while encouraging innovation and long-term stability of the sector on the other
In the past one year, the decisions by the National Pharmaceutical Pricing Authority (NPPA), including price ceilings, have led to intense discussions. Clearly, the long-term ramifications were ignored by the agency in assessing the right way forward for the fragile, wobbling healthcare system of our country. The agency will appoint a new chairman soon.